CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vifor Pharma AG Company Snapshot
Vifor Pharma AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vifor Pharma AG with three other pharmaceutical manufacturers in Europe: Recordati SpA of Italy (2018 sales of 1.35 billion Euro [US$1.49 billion] of which 84% was Specialty & Primary care), Krka DD Novo Mesto of Slovenia (1.33 billion Euro [US$1.47 billion] of which 60% was European Union), and Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag which is based in Hungary (445.48 billion Hungarian Forints [US$1.47 billion] of which 80% was Pharmaceutical Manufacturing and Sale).

Sales Analysis. During the year ended December of 2018, sales at Vifor Pharma AG were 1.58 billion Swiss Francs (US$1.60 billion). This is an increase of 18.1% versus 2017, when the company's sales were 1.34 billion Swiss Francs. Despite this increase, sales are still well below the level achieved in 2016, when Vifor Pharma AG reported sales of 4.12 billion Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vifor Pharma AG
  Stock Performance Chart for Vifor Pharma AG
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 158.10
(Figures in Swiss Francs)
1 Week -0.9%   13 Weeks 2.4%  
4 Weeks 2.7%   52 Weeks 20.9%  
 
Vifor Pharma AG Key Data:
  Ticker: VIFN Country: Switzerland
  Exchanges: GVA OTH ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,584,600,000
(Year Ending Jan 2019).
Employees: 2,700
  Currency: Swiss Francs Market Cap: 10,251,864,384
  Fiscal Yr Ends: December Shares Outstanding: 64,844,177
  Share Type: Namenaktie Closely Held Shares: 21,259,239
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.